| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/01/2004 | WO2004054433A2 Forming iron nitrosyl hemoglobin |
| 07/01/2004 | WO2004054351A2 Generation of plants with altered oil content |
| 07/01/2004 | WO2004054350A2 Generation of plants with altered oil content |
| 07/01/2004 | WO2004044591A3 Use of nuclear hormone receptors to identify meiosis regulating compounds |
| 07/01/2004 | WO2004041861A3 Alpha macroglobulin family member |
| 07/01/2004 | WO2004041859A3 Peptide fragments of the harp factor inhibiting angiogenesis |
| 07/01/2004 | WO2004033666A3 Method and compounds for inhibiting hec1 activity for the treatment of proliferative diseases |
| 07/01/2004 | WO2004029200A3 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells |
| 07/01/2004 | WO2004029087A3 Bitter taste receptors |
| 07/01/2004 | WO2004028551A9 Novel agents that modulate eph receptor activity |
| 07/01/2004 | WO2004027070A3 Transgenic expression cassettes for expressing nucleic acids in non-reproductive flower tissues of plants |
| 07/01/2004 | WO2004024881A3 LDLRs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 07/01/2004 | WO2004020600A3 Modified aav |
| 07/01/2004 | WO2004018644A3 HETEROGENEOUS FOLDAMERS CONTAINING α, β, AND/OR Ϝ-AMINO ACIDS |
| 07/01/2004 | WO2004018625A3 Ovarian cancer-specific promoter |
| 07/01/2004 | WO2004018512A3 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 07/01/2004 | WO2004018498A3 Minicell display and products therefrom |
| 07/01/2004 | WO2004013281A3 Novel proteins and their uses |
| 07/01/2004 | WO2004013168A3 Protein containing a burp domain |
| 07/01/2004 | WO2004013151A3 Campylobacter glycans and glycopeptides |
| 07/01/2004 | WO2004011636A3 Method of enzymatic deubiquitination |
| 07/01/2004 | WO2004011601A3 Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof |
| 07/01/2004 | WO2004011489A3 Tropism-modified adenoviral vectors, preferably for targeting b-lymphocytes or ovarian cells |
| 07/01/2004 | WO2004009022A3 Method for augmenting vision in persons suffering from photoreceptor cell degeneration |
| 07/01/2004 | WO2004007747A3 Assays for assembly of ebola virus nucleocapsids |
| 07/01/2004 | WO2004007540A8 Klebsiella membrane extracts exhibiting advantageous properties, and method for producing said extracts |
| 07/01/2004 | WO2004005323A3 Affinity small molecules for the epo receptor |
| 07/01/2004 | WO2004003141A3 A protein that interacts with lipids and methods for treating hyperlipidemia |
| 07/01/2004 | WO2004002216A3 Harvest-inducible genes from alfalfa (medicago sativa) and methods of use thereof |
| 07/01/2004 | WO2004001001A3 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 07/01/2004 | WO2003106694A3 Rapid methods for assessing therapeutic activity using animals expressing constitutively active g protein-coupled receptors |
| 07/01/2004 | WO2003104435A3 Cancer-linked gene as target for chemotherapy |
| 07/01/2004 | WO2003104430A3 Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes |
| 07/01/2004 | WO2003103608A3 Neuroprotective synergy of erythropoietin and insulin-like growth factor |
| 07/01/2004 | WO2003102015A3 Method and apparatus for detecting and monitoring peptides, and peptides identified therewith |
| 07/01/2004 | WO2003099996A3 Detection of secreted polypeptides |
| 07/01/2004 | WO2003099843A3 Peptide derivatives, and their use for the synthesis of silicon-based composite materials |
| 07/01/2004 | WO2003097814A3 Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins |
| 07/01/2004 | WO2003094848A3 Nucleic acid-associated proteins |
| 07/01/2004 | WO2003092582A3 Chimeric ebola virus envelopes and uses therefor |
| 07/01/2004 | WO2003091386A3 A new family of picornaviruses |
| 07/01/2004 | WO2003087757A3 Particle-bound human immunodeficiency virus envelope clycoproteins and related compositions and methods |
| 07/01/2004 | WO2003080569A3 Egfr ligands and methods of use |
| 07/01/2004 | WO2003074992A3 Phosphorylated proteins and uses related thereto |
| 07/01/2004 | WO2003072753A3 Multimeric binding complexes |
| 07/01/2004 | WO2003048202A3 Nf-kappab activating genes |
| 07/01/2004 | WO2003042240A3 Polypeptides of pseudomonas aeruginosa |
| 07/01/2004 | WO2003021265A8 Genetic construct intracellular monitoring system |
| 07/01/2004 | WO2003012045A3 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans |
| 07/01/2004 | WO2003009814A3 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
| 07/01/2004 | WO2003000038A3 Compositions and methods for modulating plant development |
| 07/01/2004 | WO2002077189A3 Glycosylation-resistant and nonglycosylated cyanovirins |
| 07/01/2004 | WO2002062834A3 Mixture of peptides originating from a nef protein and applications thereof |
| 07/01/2004 | US20040128721 Cell cycle stress-related proteins and methods of use in plants |
| 07/01/2004 | US20040128720 Preparing transgenic tomato, soybean, sugar cane and sorghum with increased growth and commercial yields when exposes to growth limiting condition |
| 07/01/2004 | US20040128719 Materials and methods for tissue-specific targeting of ethylene insensitivity in transgenic plants |
| 07/01/2004 | US20040128716 Transformation of plant cell with nucleotide sequences coding bacillus insecticidal protein generating insect resistant plants; biological pest control |
| 07/01/2004 | US20040128712 Comprises nucleotide sequences coding plant transcription factor for transformation and propagation of osmotic stress resistant and disease resistant soybean, tomatoes and rice |
| 07/01/2004 | US20040128708 Transgenic rodent encoding nucleotide sequences coding melanin concentrating hormone type 1 receptor for use in treatment of sleep and eating disorders |
| 07/01/2004 | US20040128707 Animal model for pancreatic disorder associated with signal transduction; obesity prevention |
| 07/01/2004 | US20040128706 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 07/01/2004 | US20040127696 Growth differentiation factor-7 |
| 07/01/2004 | US20040127695 Plants toxic to coleopteran insects and Ctenocephalides Spp. |
| 07/01/2004 | US20040127689 activated haptens useful for generating immunogens to HIV protease inhibitors |
| 07/01/2004 | US20040127686 Signal transduction regulator binding protein for identifying modulators for prevention and treatment of cardiomyopic hypertrophy, heart failure and diabetes; drug screening |
| 07/01/2004 | US20040127685 Novel molecules of the card-related protein family and uses thereof |
| 07/01/2004 | US20040127684 Heat shock protein-based vaccines and immunotherapies |
| 07/01/2004 | US20040127683 Membrane protein for use in diagnosis, prevention and treatment of neurological, muscular, immunological and cell proliferative disorders; drug screening |
| 07/01/2004 | US20040127682 Anti-lymphocyte globulin imunotoxin fusion protein for use in prevention and treatment of graft-versus-host disease, leukemias, lymphomas and autoimmune disorders |
| 07/01/2004 | US20040127640 Composition, method and use of bi-functional biomaterials |
| 07/01/2004 | US20040127559 with acetic acid inactivate the infectability of infectious proteins such as prions under relatively mild conditions |
| 07/01/2004 | US20040127558 Sodium dodecyl sulfate compositions for inactivating prions |
| 07/01/2004 | US20040127450 the CCRG gene, a human gene associated with cancer, antisense oligonucleotides that decreases expression of said CCRG in conjunction with chemotherapeutic agent or a radiotherapy beam |
| 07/01/2004 | US20040127447 treating a vascular disease with a recombinant adenoviral vector, encoding at least one K+ channel gene operably linked to a promoter, and a pharmaceutically acceptable excipient |
| 07/01/2004 | US20040127446 Oligonucleotide mediated inhibition of hepatitis B virus and hepatitis C virus replication |
| 07/01/2004 | US20040127445 methods for screening for compounds capable of modulating the effect of B2M activity such as inhibitors, antibodies, variants or mimetics |
| 07/01/2004 | US20040127440 osteoporosis, osteopenia and Paget's disease therapy and prevention; administering a compound that lowers NPY level in blood serum |
| 07/01/2004 | US20040127439 Introduction of the wld gene for prevention of axonal degeneration in neurological diseases |
| 07/01/2004 | US20040127438 polypeptide (or its encoding nucleic acid molecule from Mycobacterium tuberculosis or related prokaryotes in the treatment of cancer, allergic disorders or conditions of immunoactivation, particularly asthma |
| 07/01/2004 | US20040127423 coadministration with and at least one therapeutic agent selected from the group consisting of an antidiabetic agent, an anti-obesity agent, a anti-hypertensive agent, an anti-atherosclerotic agent and a lipid-lowering agent |
| 07/01/2004 | US20040127420 Metalloproteinase inhibitors for wound healing |
| 07/01/2004 | US20040127419 Methods of using truncated glial cell line-derived neurotrophic factor |
| 07/01/2004 | US20040127418 derivatives of human glucagon-like peptide-2 of improved solubility and/or stability for the treatment of obesity and small bowel syndrome |
| 07/01/2004 | US20040127417 using a poly(ethylene glycol) butyraldehyde moiety; The PEGylated hGH may have an increased plasma residency duration, decreased clearance rate, improved stability, decreased antigenicity, decreased PEGylation heterogeneity or a combination thereof |
| 07/01/2004 | US20040127415 Stresscopins and their uses |
| 07/01/2004 | US20040127412 Modified GLP-1 peptides with increased biological potency |
| 07/01/2004 | US20040127410 Circular permuteins of flt3 ligand |
| 07/01/2004 | US20040127407 capable of interfering with the prolactin signaling mechanism in a cancer cell; inhibits STAT-5 phosphorylation in a targeted cell; angiogenesis inhibiting domain can be endostatin, angiostatin or FLK-1-bp |
| 07/01/2004 | US20040127401 CA125 gene and its use for diagnostic and therapeutic interventions |
| 07/01/2004 | US20040127400 for inducing antibody production against Streptococcal antigens |
| 07/01/2004 | US20040127399 complex consisting of a divalent metal cation associated with and capable of co-precipitating with such a peptide for enhancing the expression of insulin from mammalian pancreatic B-type islet cells |
| 07/01/2004 | US20040127398 Long lasting synthetic glucagon like peptide (GLP-1) |
| 07/01/2004 | US20040126885 Delivery vehicle for recombinant proteins |
| 07/01/2004 | US20040126877 Fusion protein comprising gene expression inhibitory domains and activity for use in preventing lymphadenopathy associated viral infections via acting on/binding long terminal repeats; gene therapy and viricides |
| 07/01/2004 | US20040126871 Nucleic acid vaccines against rickettsial diseases and methods of use |
| 07/01/2004 | US20040126870 Ncc2705-the genome of a bifodobacterium |
| 07/01/2004 | US20040126866 Comprises nucleotide sequences coding cyclic nucleotide phosphodiesterases for treatment of cardiovascular, depressive and vascular disorders; cardiotonic agents; antidepressants; antihypertensives; antithrombotics |
| 07/01/2004 | US20040126862 Comprises nucleotide sequences coding protein of urogenital system for identifying moduators for treatment of cell proliferative and metastatic disorders |
| 07/01/2004 | US20040126859 Mutant forms of Fas ligand and uses thereof |
| 07/01/2004 | US20040126856 Factor ixa: factor Vllla interaction and methods therefor |